Dublin woman appeals to HSE for expensive but potentially life-saving cancer drug

A young Dublin woman is appealing to the HSE after they refused to give her a new cancer drug that could save her life.

At €100,000 per patient, per year, the health authority has said Nivolumab, known as Opdivo, is too expensive.